Abstract
Interpretation of the clinical significance of genomic alterations remains the most severe bottleneck preventing the realization of personalized medicine in cancer. We propose a knowledge commons to facilitate collaborative contributions and open discussion of clinical decision-making based on genomic events in cancer.
| Original language | English |
|---|---|
| Article number | 438 |
| Journal | Genome biology |
| Volume | 15 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 27 2014 |